JY
MJN

Jeff Yass’s Mead Johnson Nutrition Company MJN Stock Holding History

Jeff Yass’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-494,400
Closed -$44M – 10346
2017
Q1 		$44M Buy
494,400
+108,600
+28% +$8.93M 0.02% 627
2016
Q4 		$27.3M Sell
385,800
-30,900
-7% -$2.3M 0.01% 843
2016
Q3 		$32.9M Buy
416,700
+79,600
+24% +$6.79M 0.02% 714
2016
Q2 		$30.6M Sell
337,100
-298,500
-47% -$25.3M 0.02% 729
2016
Q1 		$54M Buy
635,600
+128,400
+25% +$9.55M 0.03% 497
2015
Q4 		$40M Buy
507,200
+242,800
+92% +$19.1M 0.02% 718
2015
Q3 		$18.6M Sell
264,400
-41,500
-14% -$3.41M 0.01% 1270
2015
Q2 		$27.6M Buy
305,900
+120,000
+65% +$11.6M 0.01% 1052
2015
Q1 		$18.7M Sell
185,900
-143,800
-44% -$14.5M 0.01% 1289
2014
Q4 		$33.1M Sell
329,700
-445,500
-57% -$44.4M 0.01% 978
2014
Q3 		$74.6M Buy
775,200
+520,600
+204% +$49.3M 0.03% 531
2014
Q2 		$23.7M Sell
254,600
-2,600
-1% -$227K 0.01% 1247
2014
Q1 		$21.4M Sell
257,200
-170,700
-40% -$13.8M 0.01% 1220
2013
Q4 		$35.8M Sell
427,900
-40,900
-9% -$3.33M 0.02% 868
2013
Q3 		$34.8M Buy
468,800
+173,700
+59% +$13M 0.02% 809
2013
Q2 		$23.4M Buy
+295,100
New +$23.7M 0.01% 1006

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Jeff Yass's MJN Position: Q2 2017 in Review

Jeff Yass sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 294,906 shares — an estimated $26.3M sold.

Jeff Yass first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $26.4M in Q1 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Jeff Yass reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Jeff Yass sold 294,906 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $26.3M.
  • Jeff Yass first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Jeff Yass's Mead Johnson Nutrition Company position peaked at $26.4M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.